DE510561T1 - PHARMACEUTICAL COMPOSITIONS FOR ORAL, CUTANEOUS AND INTRAVAGINAL USE IN THE FORM OF A FOAM. - Google Patents

PHARMACEUTICAL COMPOSITIONS FOR ORAL, CUTANEOUS AND INTRAVAGINAL USE IN THE FORM OF A FOAM.

Info

Publication number
DE510561T1
DE510561T1 DE1992106739 DE92106739T DE510561T1 DE 510561 T1 DE510561 T1 DE 510561T1 DE 1992106739 DE1992106739 DE 1992106739 DE 92106739 T DE92106739 T DE 92106739T DE 510561 T1 DE510561 T1 DE 510561T1
Authority
DE
Germany
Prior art keywords
compound according
active ingredient
salt
foam
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE1992106739
Other languages
German (de)
Inventor
Cesare I-20089 Quinto De' Stampi-Rozzano Milano Busetti
Germano Coppi
Stefano Poli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Poli Industria Chimica SpA
Original Assignee
Poli Industria Chimica SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ITMI911149A external-priority patent/IT1247529B/en
Application filed by Poli Industria Chimica SpA filed Critical Poli Industria Chimica SpA
Publication of DE510561T1 publication Critical patent/DE510561T1/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Claims (9)

EP 92 106 739.3 POLI INDUSTRIA CHIMICA S.p.A. PatentansprücheEP 92 106 739.3 POLI INDUSTRIA CHIMICA S.p.A. Patent claims 1. Flüssige pharmazeutische Verbindung, die als ein Schaum mittels geeigneter Versorgungsvorrichtungen verabreicht werden kann, ohne daß ein Gas-Treibmittel nötig ist, wobei die Verbindung besteht aus:1. A liquid pharmaceutical composition capable of being administered as a foam by means of suitable delivery devices without the need for a gas propellant, the composition consisting of: a) einem oder mehreren natürlichen oder synthetischen, ionischen oder nichtionischen, sauren, basischen oder neutralen Tensiden;(a) one or more natural or synthetic, ionic or non-ionic, acidic, basic or neutral surfactants; b) einem Lösungsmittel oder einem Lösungsmittelgemisch;(b) a solvent or a mixture of solvents; c) einem aktiven Bestandteil oder einer Kombination von aktiven Bestandteilen;(c) an active ingredient or a combination of active ingredients; d) fakultativ pharmazeutischen Hilfsstoffen oder Arzneistoff trägern.(d) optional pharmaceutical excipients or carriers. 2. Verbindung nach Anspruch 1, die in einer Dosierflasche enthalten ist, welche mit einem Schaum-Versorgungsventil ausgerüstet ist, das aus einer mikrogebohrten Vorrichtung besteht, an welcher die in der Flasche selbst enthaltene Lösung und ein Teil der Luft oder des Gases getrennt durch eine manuelle Betätigung an der Flasche ankommen.2. A compound according to claim 1, contained in a dosing bottle equipped with a foam supply valve consisting of a micro-drilled device to which the solution contained in the bottle itself and a portion of the air or gas arrive separately by manual actuation on the bottle. 3. Verbindung nach Anspruch 1 oder 2, bei welcher der aktive Bestandteil aus der Gruppe ausgewählt ist, welche aus antimykotischen, entzündungsverhindernden, immunmodulierenden, mukosekretolytischen, wundheilenden, erneuernden, antxphlogistischen und eine Gefäßstauung verhindernden Mitteln, Aminosäuren, Vitaminen, Corticosteroiden oder eine Kombination davon besteht.3. A compound according to claim 1 or 2, wherein the active ingredient is selected from the group consisting of antifungal, anti-inflammatory, immunomodulatory, mucosecretolytic, wound healing, rejuvenating, anti-inflammatory and anti-vasodilatory agents, amino acids, vitamins, corticosteroids or a combination thereof. 4. Verbindung nach einem der Ansprüche 1 bis 3, welche oral verabreichbar ist.4. A compound according to any one of claims 1 to 3, which is orally administrable. 5. Verbindung nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, daß der von dem Ventil-Adapter gelieferte Schaum mittels einer vaginalen Kanüle in die Vaginalöffnung ausgerichtet werden kann.5. A connection according to any one of the preceding claims, characterized in that the foam delivered by the valve adapter can be directed into the vaginal opening by means of a vaginal cannula. 6. Verbindung nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, daß der aktive Bestandteil Ciclopirox-Olamin ist.6. A compound according to any one of the preceding claims, characterized in that the active ingredient is ciclopirox olamine. 7. Verbindung nach einem der Ansprüche 1 bis 5, dadurch gekennzeichnet, daß der aktive Bestandteil ausgewählt ist von Tetridamin-Base oder ein Salz davon, Benzidamin-Base oder ein Salz davon, Pidotimod-Base oder ein Salz7. A compound according to any one of claims 1 to 5, characterized in that the active ingredient is selected from tetridamine base or a salt thereof, benzidamine base or a salt thereof, pidotimod base or a salt oder ein Derivat davon, Triticum Vulgare-Extrakt, hydrolösliche oder fettlösliche Vitamine oder Aminosäuren in Kombination und/oder Mineralsalze, Carboxymethylcystein und/oder die Salze oder Derivate davon, Sobrerol, 3-Cyclopropylmethylxanthin, Hydrocortison oder die Salze davon, Piroxicam oder ein Komplex mit Cyclodextrxnen davon, Ketoprofen oder das Salz davon und Diclofenac oder das Salz davon.or a derivative thereof, Triticum Vulgare extract, hydrosoluble or fat-soluble vitamins or amino acids in combination and/or mineral salts, carboxymethylcysteine and/or the salts or derivatives thereof, sobrerol, 3-cyclopropylmethylxanthine, hydrocortisone or the salts thereof, piroxicam or a complex with cyclodextrins thereof, ketoprofen or the salt thereof and diclofenac or the salt thereof. 8. Verbindung nach den Ansprüchen 6 oder 7, bei welcher der aktive Bestandteil in einer Menge zwischen 0.05% und 20% w/v enthalten ist.8. A compound according to claims 6 or 7, wherein the active ingredient is present in an amount between 0.05% and 20% w/v. 9. Verbindung nach den Ansprüchen 6 oder 7, bei welcher der aktive Bestandteil in einer Menge zwischen 1% und 3% w/v enthalten ist.9. A compound according to claims 6 or 7, wherein the active ingredient is present in an amount between 1% and 3% w/v.
DE1992106739 1991-04-24 1992-04-21 PHARMACEUTICAL COMPOSITIONS FOR ORAL, CUTANEOUS AND INTRAVAGINAL USE IN THE FORM OF A FOAM. Pending DE510561T1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI911149A IT1247529B (en) 1991-04-24 1991-04-24 PHARMACEUTICAL COMPOSITIONS IN FOAM FORM FOR INTRAVAGINAL, SKIN AND ORAL ADMINISTRATION

Publications (1)

Publication Number Publication Date
DE510561T1 true DE510561T1 (en) 1993-04-08

Family

ID=11359784

Family Applications (2)

Application Number Title Priority Date Filing Date
DE1992106739 Pending DE510561T1 (en) 1991-04-24 1992-04-21 PHARMACEUTICAL COMPOSITIONS FOR ORAL, CUTANEOUS AND INTRAVAGINAL USE IN THE FORM OF A FOAM.
DE1992612371 Expired - Lifetime DE69212371T2 (en) 1991-04-24 1992-04-21 Pharmaceutical compositions for oral, cutaneous and intravaginal use in the form of a foam

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE1992612371 Expired - Lifetime DE69212371T2 (en) 1991-04-24 1992-04-21 Pharmaceutical compositions for oral, cutaneous and intravaginal use in the form of a foam

Country Status (5)

Country Link
AT (1) ATE140623T1 (en)
CA (1) CA2066945C (en)
CZ (1) CZ283238B6 (en)
DE (2) DE510561T1 (en)
RU (1) RU2093146C1 (en)

Also Published As

Publication number Publication date
CA2066945A1 (en) 1992-10-25
ATE140623T1 (en) 1996-08-15
DE69212371T2 (en) 1997-01-16
RU2093146C1 (en) 1997-10-20
CA2066945C (en) 2004-06-22
CZ283238B6 (en) 1998-02-18
CS123992A3 (en) 1992-11-18
DE69212371D1 (en) 1996-08-29

Similar Documents

Publication Publication Date Title
EP0510561B1 (en) Oral, cutaneous and intravaginal pharmaceutical compositions in the form of foam
DE69206345T2 (en) Intranasal drugs containing Ketorolac R.
JP3240330B2 (en) Pharmaceutical and cosmetic preparations containing salts of colanic acid
US4661524A (en) Topical treatment and composition
AU776318B2 (en) Topical zinc compositions and methods of use
DE3382616T2 (en) MEDIATOR OF THE PENETENTIALITY FOR THE TRANSDERMAL ADMINISTRATION OF SYSTEMIC ACTIVE SUBSTANCES.
AU633892B2 (en) Moisturizing vehicle for topical application of vitamin a acid
CA2628857A1 (en) Formulation and method for treating neoplasms by inhalation
EP0692250B1 (en) Formulations containing esculoside and the use thereof in the pharmaceutical and cosmetic fields
CA2419404A1 (en) Compositions and methods for treating sexual dysfunction
EP1477166A1 (en) The use of riluzol combined with excipients and additives for the treatment of disorders characterised by hyperproliferation of keratinocytes, in particular neurodermitis and psoriasis
JP2609564B2 (en) Cream for allergic dermatitis and method for producing the same
ATE309816T1 (en) TOPICAL MEDICINAL PRODUCT CONTAINING CICLOSPORINE
JPH1112136A (en) Minoxidil-formulated aerosol
DE510561T1 (en) PHARMACEUTICAL COMPOSITIONS FOR ORAL, CUTANEOUS AND INTRAVAGINAL USE IN THE FORM OF A FOAM.
US5036050A (en) Compositions containing thymopentin for topical treatment of skin disorders
JPH03291221A (en) Liquid for external use for skin
KR0137206B1 (en) Spray gel base and spray gel preparation thereof
HUP0002533A2 (en) New combination of antiasthma medicaments
JP2005314434A (en) Use of composition containing one chelating agent for reducing symptoms associated with histamine release in organism
JPH0899877A (en) Dermatological medicine against heavy infection,containing content of fatty acid and fatty acid glyceride
JPH045221A (en) Composition for oral cavity
CA2259270A1 (en) Pharmaceutical preparation containing nimesulide for oral administration
DE3882353T2 (en) Antitussive compositions and a process for their preparation.
JP2006062968A (en) Dropsy-improving agent